CESANA GIANCARLO
Publications
Arnold, N., Blaum, C., Gossling, A., Brunner, F., Bay, B., Ferrario, M., et al. (2024). C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project. EUROPEAN HEART JOURNAL, 45(12), 1043-1054 [10.1093/eurheartj/ehad867]. Detail
Arnold, N., Blaum, C., Goßling, A., Brunner, F., Bay, B., Zeller, T., et al. (2024). Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol– or Apolipoprotein B–Related Risk of Coronary Heart Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 84(2 (9 July 2024)), 165-177 [10.1016/j.jacc.2024.04.050]. Detail
Faverio, P., Fumagalli, A., Conti, S., Madotto, F., Bini, F., Harari, S., et al. (2023). Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis. ANNALS OF THE AMERICAN THORACIC SOCIETY, 20(7), 1066-1070 [10.1513/AnnalsATS.202211-935RL]. Detail
Antonazzo, I., Fornari, C., Rozza, D., Conti, S., Di Pasquale, R., Cortesi, P., et al. (2022). Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study. JOURNAL OF CLINICAL MEDICINE, 11(24) [10.3390/jcm11247492]. Detail
Antonazzo, I., Fornari, C., Rozza, D., Conti, S., Di Pasquale, R., Cortesi, P., et al. (2022). Azithromycin use and outcomes in patients with COVID-19: an observational real-world study. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 124(November 2022), 27-34 [10.1016/j.ijid.2022.09.005]. Detail